NOI Modulight Inc. 75N98026Q00862.pdf
PDF 79 KB Posted
- Attached to
- Modulight ML6600 laser platform
- Solicitation number
- 75N98026Q00862
About this file
This is a Notice of Intent for a sole source acquisition issued by the National Cancer Institute (NCI). The contracting activity seeks to acquire a Modulight ML6600 laser platform from Modulight, Inc., the sole proposed contractor. The justification for sole source procurement under FAR 6.302-1 states that Modulight Inc. is the only known responsible source capable of meeting NCI's compatibility and continuity requirements. The laser platform will support in vitro studies with cultured cells, hosting multiple laser wavelengths while remaining compact for transportation between laboratories. Treatment will occur on a microscope stage with real-time observation and recording of cell morphology. The platform is essential for determining optimal light irradiation conditions for near-infrared photoimmunotherapy (NIR-PIT) and supporting continued technology development for future clinical applications.
Interested small businesses, including those in designated categories (8(a), service-disabled veteran-owned, HUBZone, small disadvantaged, veteran-owned, and women-owned), may submit written capability statements by 09:00 a.m. EDT on August 29, 2026, to danielt@mail.nih.gov. Submission of capability statements does not obligate the Government to compete the procurement, with any competition decision made at the Government's sole discretion. An award is anticipated approximately five days after the notice closing date unless the Government determines another vendor can satisfy the requirement.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
NOTICE OF INTENT: Modulight ML6600 laser platform (75N98026Q00862)
Sole Source Justification and Notice Authority: FAR 6.302-1 — Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements
Contracting Activity: National Cancer Institute (NCI)
Proposed Contractor: Modulight, Inc.
Description of Requirement: Modulight ML6600 laser platform
Justification for Sole Source:
Only One Source: Modulight Inc. is the only known responsible source capable of providing the required services that meet NCI compatibility, and continuity requirements in accordance with
FAR 6.302-1.
Modulight ML6600 laser platform will be used for in vitro studies with cultured cells. The platform can host lasers of various wavelengths and is compact that can be transported between labs for pre-clinical studies.
The treatment will be carried out on the microscope stage, and cell morphology will be observed and recorded in real time.
This platform is necessary to determine the optimal light irradiation conditions for NIR-PIT and to support continued development of technology for future clinical applications.
Small Business Notification: This notice is not a request for competitive quotes. However, any interested small businesses (including 8(a), service-disabled veteran-owned, HUBZone, small disadvantaged, veteran-owned, and women-owned small businesses) may submit a written capability statement demonstrating their ability to perform the requirement. Submission of capability statements does not constitute a commitment by the Government to compete the proposed award; any decision to compete will be made at the Government’s sole discretion.
Anticipated Award Date: An award is anticipated approximately five (5) days after the date of this notice closes unless the Government determines another vendor can meet the requirement.
Please email responses to danielt@mail.nih.gov no later than 09:00 a.m. EDT on August 29, 2026.
File details come from the government source that posted it. Updated .